Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
Janet E. Murphy(Harvard University), Theodore S. Hong(Massachusetts General Hospital), Jason E. Faris(Royal Marsden NHS Foundation Trust), Leilana Ly(Harvard University), Thomas F. DeLaney(Massachusetts General Hospital), Dan G. Duda(Harvard University), Colin D. Weekes(Massachusetts General Hospital), Yves Boucher(Harvard University), Motaz Qadan(Massachusetts General Hospital), Ryan B. Corcoran(Massachusetts General Hospital), Aparna R. Parikh(Massachusetts General Hospital), Christian Baglini(Brigham and Women's Hospital), David L. Berger(Harvard University), Keith D. Lillemoe(Harvard University), Lipika Goyal(Stanford Medicine), Cristina R. Ferrone(Cedars-Sinai Medical Center), David P. Ryan(East Carolina University), Jennifer Y. Wo(Massachusetts General Hospital), Nilesh P. Talele(Harvard University), Lawrence S. Blaszkowsky(Brigham and Women's Hospital), Jeffrey W. Clark(Massachusetts General Hospital), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Wenqing Jiang(Waseda University), Eunice L. Kwak(Harvard University), Carlos Fernández-del Castillo(Massachusetts General Hospital), Jill N. Allen(Harvard University), Lorraine C. Drapek(Harvard University), Ryan David Nipp(Harvard University), Beow Y. Yeap(Harvard University), David T. Ting(Massachusetts General Hospital)
Cited by 518
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k